Atrium Health Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina

Atrium Health Wake Forest Baptist Comprehensive Cancer Center is a clinical research site located in Winston-Salem, North Carolina, United States 27103.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Atrium Health Wake Forest Baptist Comprehensive Cancer Center has participated in 24 clinical trials with 22 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Large B-cell Lymphoma, Lymphoma, B-Cell.

Sponsors: Wake Forest University Health Sciences, Lyell Immunopharma, Inc., Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atrium Health Wake Forest Baptist Comprehensive Cancer Center?

Atrium Health Wake Forest Baptist Comprehensive Cancer Center has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atrium Health Wake Forest Baptist Comprehensive Cancer Center conducted?

Atrium Health Wake Forest Baptist Comprehensive Cancer Center has 24 clinical trials on record, with 22 currently active. Their work covers Acute Myeloid Leukemia, Large B-cell Lymphoma, Lymphoma, B-Cell.

Is Atrium Health Wake Forest Baptist Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Atrium Health Wake Forest Baptist Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Atrium Health Wake Forest Baptist Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.